Westrock Coffee Company to Report Fourth Quarter 2024 Financial Results on March 11, 2025

(NasdaqGM:WEST), LITTLE ROCK, Ark., Feb. 18, 2025 (GLOBE NEWSWIRE) — Westrock Coffee Company (NASDAQ: WEST) (“Westrock Coffee” or the “Company”) today announced that it will report its fourth quarter 2024 results on Tuesday, March 11, 2025 after market close. The announcement will be followed by a live earnings conference call at 4:30 p.m. ET. To […]

NeuroPace Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

(NasdaqGM:NPCE), MOUNTAIN VIEW, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) — NeuroPace, Inc. (Nasdaq: NPCE) today announced the completion of its previously announced underwritten public offering of 7,475,000 shares of its common stock at a public offering price of $10.00 per share, including 975,000 shares sold pursuant to the exercise in full of the underwriters' option

Devon Energy Reports Fourth-Quarter 2024 Results and Declares and Raises Quarterly Dividend

(NYSE:DVN), OKLAHOMA CITY, Feb. 18, 2025 (GLOBE NEWSWIRE) — Devon Energy Corp. (NYSE: DVN) today reported financial and operational results for the fourth-quarter 2024. The company also declared its quarterly dividend and provided a 2025 outlook. Devon's earnings release, supplemental financial tables, guidance and related earnings presentation can be accessed via the Investor Relations section

Allbirds Announces Fourth Quarter and Full Year 2024 Earnings Conference Call

(NASDAQ:BIRD), SAN FRANCISCO, Feb. 18, 2025 (GLOBE NEWSWIRE) — Allbirds, Inc. (NASDAQ: BIRD), a global lifestyle brand that innovates with sustainable materials to make products in a better way, today announced that its fourth quarter and full year 2024 financial results will be released after market close on Tuesday, March 11, 2025. The company will

Cricut to Present at Upcoming Investor Conference

(NASDAQ:CRCT), SOUTH JORDAN, Utah, Feb. 18, 2025 (GLOBE NEWSWIRE) — Cricut, Inc. (“Cricut”) (NASDAQ: CRCT), the creative technology company that has brought a connected platform for making to millions of users worldwide, today announced that members of its management team are scheduled to present at an upcoming investor conference. Details of the event are as

ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025, at 8:00 a.m. ET

(NasdaqGM:ANIP), PRINCETON, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its fourth quarter and full year 2024 financial results on Friday, February 28, 2025, prior to the market open. Nikhil Lalwani, President and Chief Executive Officer, Stephen P. Carey, Senior

Rush Enterprises, Inc. Reports Fourth Quarter and Year-End 2024 Results, Announces $0.18 per Share Dividend

(NASDAQ:RUSHA),(NASDAQ:RUSHB), Annual revenues of $7.8 billion; net income of $304.2 million Annual earnings per diluted share of $3.72 4th quarter revenues of $2.0 billion; net income of $74.8 million Board declares cash dividend of $.18 per share of Class A and Class B common stock SAN ANTONIO, Feb. 18, 2025 (GLOBE NEWSWIRE) — Rush Enterprises,

ORIC(R) Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Updates

(NASDAQ:ORIC), Reported encouraging early safety and efficacy data in ongoing dose escalation trial for ORIC-944 in combination with androgen receptor inhibitors in patients with mCRPC Entered into clinical trial collaboration and supply agreement with Johnson & Johnson to evaluate ORIC-114 in combination with subcutaneous amivantamab for the first-line treatment of NSCLC patients with EGFR exon

Safe Bulkers, Inc. Reports Fourth Quarter and Twelve Months 2024 Results and Declares Dividend on Common Stock

(NYSE:SB),(NYSE:SB-PC),(NYSE:SB-PD), MONACO, Feb. 18, 2025 (GLOBE NEWSWIRE) — Safe Bulkers, Inc. (the “Company”) (NYSE: SB), an international provider of marine drybulk transportation services, announced today its unaudited financial results for the three and twelve month periods ended December 31, 2024. The Board of Directors of the Company also declared a cash dividend of $0.05 per

Clover Health to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

(NASDAQ:CLOV), WILMINGTON, Del., Feb. 18, 2025 (GLOBE NEWSWIRE) — Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), today announced that it will report fourth quarter and full year 2024 financial results after market close on Thursday, February 27, 2025. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on February 27,

Scroll to Top